Vitaspring Biomedical (VSBC) Consolidated Net Income (2017 - 2026)
Vitaspring Biomedical (VSBC) posted Consolidated Net Income of -$155,817 for fiscal Q2 2027 (quarter ended Jul 31, 2026), compared with -$110,845 a year earlier.
Vitaspring Biomedical (VSBC) Consolidated Net Income (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jul 31, 2026, Consolidated Net Income at Vitaspring Biomedical was -$455,643; for FY2026 (ended Jan 31, 2026), it came in at -$415,368.
- In prior fiscal years, Vitaspring Biomedical's Consolidated Net Income was -$774,922 in FY2025, -$1.12 million in FY2024, -$77,556 in FY2023 and $909,560 in FY2022.
- The fiscal Q2 2027 figure stands as the lowest quarterly Consolidated Net Income since fiscal Q3 2025.
- According to Business Quant data, Consolidated Net Income for the three prior fiscal quarters was -$75,844 (Q1 2027), -$81,464 (Q4 2026) and -$142,518 (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Vitaspring Biomedical | 2.07 Mn | 2.04 Mn | - | -155,817.00 |
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -155,817.00 |
| Apr 30, 2026 | -75,844.00 |
| Jan 31, 2026 | -81,464.00 |
| Oct 31, 2025 | -142,518.00 |
| Jul 31, 2025 | -110,845.00 |
| Apr 30, 2025 | -80,541.00 |
| Jan 31, 2025 | -143,137.00 |
| Oct 31, 2024 | -196,292.00 |
| Jul 31, 2024 | -218,662.00 |
| Apr 30, 2024 | -216,831.00 |
| Jan 31, 2024 | -225,398.00 |
| Oct 31, 2023 | -234,980.00 |
| Jul 31, 2023 | -353,583.00 |
| Apr 30, 2023 | -304,601.00 |
| Jan 31, 2023 | -4.16 Mn |
| Oct 31, 2022 | -138,004.00 |
| Jul 31, 2022 | -144,135.00 |
| Apr 30, 2022 | 276,656.00 |
| Jan 31, 2022 | 1.23 Mn |
| Oct 31, 2021 | -137,453.00 |
Vitaspring Biomedical Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=VSBC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "VSBC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=VSBC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();